Dr. Andrés Poveda Velasco is one of Spain’s top medical oncologists, highly regarded for his expertise in gynecological tumours and sarcomas. Based in Valencia, he currently serves as Coordinator and Specialist at the Initia Integrative Cancer Centre and as a senior consultant at Hospital Quirónsalud Valencia. A recognized authority, he’s been honored in the Top Doctors 2018 list by his peers. With fluency in English, German, Italian, and Spanish, Dr. Poveda connects seamlessly with a global patient community. His blend of clinical excellence, research leadership, and compassionate care positions him as a famous figure and the best doctor in Spain’s oncology landscape.
Dr. Poveda’s clinical and research focus lies in gynecological cancers—particularly ovarian, endometrial, and cervical cancer—as well as soft tissue sarcomas and GISTs. As principal investigator in numerous national and international clinical trials, he has propelled advances in targeted therapies, including PARP inhibitors like olaparib, which extended overall survival in platinum‑sensitive, relapsed ovarian cancer. Dr. Poveda collaborates closely with cooperative research networks such as GEICO, GEIS, EORTC-STSB, and GCIG. A prolific researcher with over 80 peer-reviewed publications in leading journals, he also sits on editorial boards and has co-authored landmark ovarian cancer consensus guidelines. His clinical acumen, combined with his trailblazing research, makes him a leading specialist, the best choice, and a top expert for complex gynecological oncology cases.